Background: Within the genus Aspergillus, A. flavus is the second most important species of clinical significance. It is predominantly associated with infections involving sinuses, eye and skin, mostly in geographic regions with hot and arid climate, including the Middle East. Recent reports on emergence of resistance to triazoles among Aspergillus spp. is a cause of concern for treatment of patients with invasive aspergillosis. In this study we present data on genetic characterization and antifungal susceptibility profile of clinical and environmental isolates of A. flavus.
spore-forming filamentous fungi [13] . Recently, epidemiologic cutoff values (ECVs) for triazoles and caspofungin for wild-type strains of Aspergillus spp. have been developed [14] [15] [16] . However, due to interspecies/inter-strain differences in MICs, clinical breakpoints for each Aspergillus spp. are not yet available. Occurrence of azole resistance among wild-type strains of A. fumigatus due to mutations in cyp51A gene and possibility of finding similar resistance in other Aspergillus spp [17, 18] have necessitated the need to evaluate efficacy of simple agar-based methods for antifungal susceptibility testing. Preliminary studies have suggested that disk diffusion test and Etest show comparable results with BMD method for susceptibility testing with azoles [19] [20] [21] [22] . Here, we present molecular characterization and MIC results of six antifungal agents tested against 99 A. flavus isolates by Etest and compare amphotericin B and voriconazole MICs with zone of inhibition diameters obtained by disk diffusion test.
Methods

Aspergillus flavus isolates
Ninety-two clinical and 7 environmental isolates of A. flavus were included in the study ( Table 1 ). The clinical isolates were recovered from a variety of specimens over an 18-year period (1993-2011) . They were deposited in the culture collection of the Mycology Reference Laboratory and maintained by periodic sub-culture. Since the isolates were obtained during routine mycological investigations, there was no ethical requirement to take approval from individual patients for their subsequent use. The study (Project No. YM 03/10) was approved by the Ethical Committee of Faculty of Medicine, Health Sciences Center, Kuwait University. All isolates were identified as A. flavus by typical colony and microscopic characteristics as described by Klich [23] . The isolates were also characterized and speciated by molecular methods.
Molecular characterization
The genomic DNA from the isolates was prepared as described previously and used as template for PCR amplification [24] . The ITS region (ITS-1, 5.8 S rRNA and ITS-2) of rDNA was amplified with Aspergillus section Flavi-specific AFLF and AFLR primers as described in detail previously [10] . The species-specific identification of all isolates was studied by partial sequencing of β-tubulin and calmodulin gene fragments. The variable region of β-tubulin gene was amplified by using BTUBF (5 0 -TGGTAACCAAATCGG TGCTGCTT-3 0 ) and BTUBR (5 0 -GCACCCTCAGTGT AGTGACCCT-3 0 ) primers while the variable region of calmodulin gene was amplified by using Cmd5 (5 0 -GTCT CCGAGTACAAGGAGGC-3 0 ) and Cmd6 (5 0 -TCGCCG ATRGAGGTCATRACGTG-3 0 ) primers and the amplicons were sequenced as described previously [25] . GenBank basic local alignment search tool (BLAST) searches (http:// blast.ncbi.nlm.nih.gov/blast/Blast.cgi?) were performed for species identification. The DNA sequences for type strains already available in GenBank were retrieved. The gene sequences were analyzed individually or nucleotide sequences of both, β-tubulin and calmodulin gene fragments were included in the combined analysis. Multiple sequence alignments were performed with ClustalX version 2.0. The phylogenetic trees were constructed using the neighborjoining method with pair-wise deletion of gaps option. Aspergillus parasiticus (CBS100926) was chosen as the outlying taxon and the robustness of branches was assessed by bootstrap analysis with 1,000 replicates.
Antifungal susceptibility testing Preparation of inoculum
All isolates were freshly sub-cultured on potato dextrose agar (PDA) slants to obtain good sporulation. The culture tubes were flooded with 1 ml of 0.9% saline and vortexed for 15 seconds to dislodge the conidia. The growth suspensions were transferred to another sterile tube containing 1.5-ml saline and 0.2% Tween 80. A conidial suspension containing approximately 0.4 × 10 4 to 5 × 10 4 cells was used as inoculum [13] . Reference strains of A. flavus (CBS100927) and A. parasiticus (CBS100926) were included with each batch of susceptibility testing to ensure quality control.
Etest
Two media, namely, RPMI 1640 supplemented with 2% glucose (pH adjusted to 7.0 with morpholinepropanesulfonic acid buffer) and Mueller-Hinton (MH) II agar (Becton, Dickinson and Company, Sparks, MD, USA) , which are generally one step higher than A. fumigatus [14] [15] [16] .
Disk diffusion test
For the purpose of comparing zone of inhibition results, the disk diffusion test was performed on RPMI 1640 medium supplemented with 2% glucose instead of Mueller-Hinton agar medium. Disk diffusion disks for voriconazole (1-μg) and amphotericin B (100-μg) were obtained commercially (Bio-Rad Laboratories, Marnesla-Coquette, France). After applying the discs, the plates were incubated at 35°C for 24 h. Zone diameters were measured at the point where the growth significantly decreased (80 to 100% inhibition) and were recorded to the nearest millimeter. Recently, Espinel-Ingroff et al. proposed for the first time quality control and reference zone diameter limits for A. fumigatus (ATCC MYA-3626) for amphotericin B (10-μg disk), itraconazole (10-μg disk), posaconazole (10-μg disk), and voriconazole (10-μg disk) [27] . No quality control ranges were recommended for A. flavus and A. terreus, because some results did not meet M23-A3 document requirements [28] . However, for A. flavus, the acceptable zone diameter ranges for voriconazole and posaconazole were proposed as 25-36 mm and 27-37 mm, respectively.
Statistical analysis
The Spearman correlation test was performed to determine the correlation between Etest MICs and zone of inhibition diameters. A P value of <0.05 was considered as significant. Independent samples T test was used to compare mean MIC values of A. flavus strains isolated in two different periods of 9-year each (1993-2001 and 2002-2011) .
Results
Molecular characterization
All 99 A. flavus isolates included in this study were identified as belonging to Aspergillus section Flavi by specific amplification of a DNA fragment of expected size (~243 bp) in PCR with Aspergillus section Flavi-specific primers AFLF and AFLR [10] . The partial β-tubulin DNA sequences from 94 isolates were completely identical and showed no difference with sequence from reference A. flavus (CBS100927) strain while the sequences of remaining 5 isolates differed at only 1 nucleotide position. The calmodulin gene sequences of the 99 isolates were more variable (total 8 patterns) but still showed maximum identity with sequence from reference A. flavus (CBS100927) strain than with reference strains of other species belonging to Aspergillus section Flavi. [29] . The combined β-tubulin and calmodulin gene sequences of the 99 isolates also showed maximum identity with sequence from reference A. flavus (CBS100927) strain. Pair-wise sequence comparisons showed that all 99 isolates exhibited 11 different patterns with three large clusters corresponding to 3 patterns containing 78 isolates ( Table 2 ). The neighbor-joining phylogenetic tree based on combined data set for β-tubulin and calmodulin gene sequences (using only one representative isolate from each of 11 patterns) is shown in Figure 1 . All 11 representative A. flavus isolates from Kuwait clustered together with A. flavus strains on a separate branch. The unique DNA sequencing data reported here have been submitted to EMBL under accession nos. HF570030-HF570051.
Antifungal susceptibility
The results of Etest antifungal susceptibility of clinical isolates of A. flavus are presented in Table 3 . The mean and range of MIC values of seven environmental A. flavus isolates on RPMI medium for the six antifungal agents were as follows: amphotericin B, 1.25 μg/ml ± 0.577 (range 0.75-2 μg/ml); voriconazole, 0.138 μg/ml ± 0.050 (range 0.094-0.25 μg/ml); posaconazole, 0.079 μg/ml ± 0.087 (range 0.008-0.25 μg/ml); anidulafungin, 0.002 μg/ml ± 0.00 (range 0.002-0.002 μg/ml); micafungin, 0.002 ± 0.00 (range 0.002-0.002 μg/ml) and caspofungin, 0.071 μg/ml ± 0.082 (range 0.008-0.19 μg/ml), respectively. These mean MIC values were comparable with those obtained on MH-GMB medium. None of the environmental isolates exhibited MIC value of >2 μg/ml for amphotericin B.
Disk diffusion test
Using amphotericin B (100-μg) and voriconazole (1-μg) disks, the mean values for zone of inhibition for clinical isolates were 10.38 ± 1.655 mm (range 7-16 mm) and 28.88 ± 2.321 mm (24-34 mm), respectively ( Table 5) . For environmental isolates, the mean values for zone of inhibition were 10.71 ± 1.38 mm (range 8-12 mm) and 27.71 ± 1.603 mm (26-30 mm) for amphotericin B and voriconazole, respectively. The differences in inhibition zone diameters between clinical and environmental isolates for voriconazole and amphotericin B were not statistically significant. Linear regression analysis between Etest MIC values and disk diffusion diameters obtained with clinical isolates revealed a significant inverse correlation, both with amphotericin B (R 2 = 0.2536, p <0.001) and voriconazole (R 2 = 0.4043, p<0.003).
Discussion
This study provides molecular characterization and in vitro antifungal susceptibility data on clinical and [33] . Notably, survival rate was much lower among patients who yielded resistant strains (22% versus 67%) and were treated with amphotericn B. Similar results were obtained in a previous study [31] . However, with the introduction of voriconazole as a primary therapy for invasive aspergillosis, the concerns about amphotericin B resistance have been largely addressed in resourcerich countries. All our A. flavus isolates were inhibited at a concentration of ≤0.256 μg/ml, which is lower or equal to the recently proposed clinical breakpoints for resistance to voriconazole (>2 μg/ml) and posaconazole (>0.25μg/ml) for A. fumigatus complex isolates [26] . Consistent with our observations, none of the 98 A. flavus clinical isolates tested in the Netherlands exhibited resistance to itraconazole or voriconazole [17] . So far, acquired resistance to azoles in A. flavus is extremely rare [34] . However, recent reports of voriconazole resistance in an A. flavus isolate cultured from lung specimen of a patient in China and a case of voriconazole-refractory eye infection in a patient from India have posed new therapeutic challenges [35, 36] . It is unclear why itraconazole/ voriconazole-resistance among A. flavus isolates is so rare despite their wide-spread environmental prevalence and exposure to same azole fungicides that are apparently related to development of resistance in A. fumigatus [17] , more so, when voriconazole-resistant strains of A. flavus can be readily obtained in the laboratory [37] . Although we tested only seven environmental isolates of A. flavus, their mean MIC values were marginally lower than clinical isolates for voriconazole and posaconazole but higher for amphotericin B. In one previous study, MIC values of environmental isolates (n=59) for amphotericin B and itraconazole were found to be significantly lower than the clinical isolates (n=29) (p < 0.05) [38] .
All three echinocandins showed good in vitro activity against A. flavus by Etest. Consistent with several A limitation of our study is the non-availability of BMD data for comparison with Etest MICs. Similar to some other studies, we also ignored the presence of microcolonies within the Etest inhibition zone [21, 22] . A good concordance has been reported between MICs obtained by Etest and BMD test for posaconazole (84% to 98%) [41, 42] , itraconazole (100%) [43, 44] , and voriconazole (85%) [44] [45] [46] against Aspergillus spp. at both, 24 and 48 h readings in studies that have used these two methods. Recently, Colozza et al. compared CLSI and Etest MICs for determining Aspergillus spp. susceptibility to amphotericin B and AmBisome [30] . A high percentage of A. flavus complex isolates were resistant (>1 μg/ml) to AmBisome (43.7%) than amphotericin B (16.7%) by BMD. This was in contrast with the amphotericin B susceptibility results obtained by BMD method for the same isolates, but not with those obtained by the Etest. The authors inferred that Etest may be a superior method than BMD for determining amphotericin B-resistant Aspergillus strains, perhaps because of the wider range of MIC distribution available on the Etest strip.
There is paucity of data on correlation between inhibition zone diameters and Etest MICs against Aspergillus spp. A few studies available in the literature suggest that agar diffusion methods have potential value for evaluating susceptibility to antifungal agents [47, 48] . In a multicenter study, Espinel-Ingroff et al. evaluated agar diffusion method for susceptibility testing of filamentous fungi on plain Muller-Hinton agar medium [47] . The investigators suggested that using 5-μg disk of posaconazole and caspofungin, 1-μg disk of voriconazole, and 10-μg disk for itraconazole, and an incubation time of 24 h are optimal for determining susceptibility of three Aspergillus spp. (A. fumigatus, A. flavus, and A. niger). Recently, Espinel-Ingroff et al. [27] , following CLSI described guidelines [49] , established zone diameter limits for disk diffusion susceptibility testing for A. fumigatus. No quality control ranges were recommended for A. flavus and A. terreus as some of the results did not satisfy the M23-A3 document requirements [28] . However, the zone diameter ranges of 27 to 37 mm for posaconazole and 25 to 36 mm for voriconazole obtained by the authors for A. flavus isolates were considered acceptable. We obtained a comparable zone diameter range of 24 to 34 mm with 1-μg voriconazol disk, whereas zone diameters for amphotericin B were much narrower (7 to 16 mm) despite the fact that we used 100-μg disks. More recently, Martos et al. evaluated disk diffusion method for determining susceptibility to echinocandins [21] . For all Aspergillus spp. (including 18 A. flavus isolates), caspofungin disk provided narrower zone of inhibition (14-29 mm) than micafungin (14-40 mm) and anidulafungin (22-45 mm) at 24 h incubation, which is in concordance with relatively higher Etest MICs obtained with caspofungin than micafungin and anidulafungin obtained in the present study.
Conclusion
All 92 clinical isolates collected over an 18-year period in Kuwait and phenotypically identified as A. flavus, were also characterized as A. flavus strains by partial sequencing of β-tubulin and calmodulin gene fragments. The triazoles and echinocandins showed good activity against clinical as well as environmental A. flavus isolates, however, nearly 11% and 18% isolates showed MIC of >2 μg/ml against amphotericin B on RPMI agar medium and Mueller-Hinton agar medium, respectively. There was a significant inverse correlation between Etest MICs and inhibition zone diameter values with voriconazole and amphotericin B. To the best of our knowledge, this is the first study reporting results of molecular characterization of A. flavus isolates from the Middle East. 
